| Biomarker ID | 1663 |
| PMID | 30911973 |
| Year | 2019 |
| Biomarker | SNHG6 (small nucleolar RNA host gene 6) |
| Biomarker Basis | Expression Based |
| Biomolecule | LncRNA |
| Source | Cell Lines |
| Subjects | Humans |
| Regulation | Upregulated in T2 PCa and T3+T4 PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathway include: NHG6 was involved in structural constituents of ribosome, poly(A) RNA binding, RNA binding, protein binding and NADH dehydrogenase (ubiquinone) activity |
| Experiment | Normal Cell Lines Vs PCa Cell Lines |
| Type of Biomarker | Diagnostic |
| Cohort | Prostate cancer cell lines: NCaP, 22Rv1, PC-3 and DU145 were tested along with normal prostate cell line: WPMY-1 |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.001 |
| Method Used | qRT-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | NA |